Gabapentin Capsule
Product Images NDC 72162-1532

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 72162-1532). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Image 01)

A line graph showing mean pain scores over an 8-week period, comparing Placebo and Gabapentin 3600 mg/day groups. The x-axis represents weeks from baseline to 8 weeks, with a 4-week dose titration period followed by a 4-week fixed dose period. The y-axis shows mean pain scores from 0 to 10.*

FDA Label Image

Figure 2 (Image 02)

Line graph showing mean pain scores over a 7-week period for placebo, gabapentin 1800 mg/day, and gabapentin 2400 mg/day groups. The x-axis represents weeks including a 3-week dose titration period and a 4-week fixed dose period. The y-axis shows mean pain scores from 0 to 10, with both gabapentin groups showing a decline in pain scores compared to placebo.*

FDA Label Image

Figure 3 (Image 03)

A bar chart titled 'Figure 3. Proportion of Responders (patients with ≥ 50% reduction in pain score) at Endpoint: Controlled PHN Studies' comparing placebo (PBO) to Gabapentin (GBP) doses in two studies. The y-axis shows percentage responders from 0% to 100%. Study 1 shows 12% responders for PBO and 29% for GBP 3600 mg. Study 2 shows 14% for PBO, 32% for GBP 1800 mg, and 34% for GBP 2400 mg. Statistical significance indicators are included (p < 0.01 and p < 0.001).*

FDA Label Image

Cockcroft And Gault Equation (Image 04)

A formula displaying the equation for calculating creatinine clearance (CLCr), involving age, weight, serum creatinine, and a factor adjustment for female patients. This is not a chemical structure but a pharmacokinetic calculation formula.*

FDA Label Image

Gabapentin Structural Formula (Image 05)

Chemical structure of Gabapentin showing the cyclohexane ring attached to a side chain with amine and carboxylic acid functional groups.*

FDA Label Image

Image-09 (Image 09)

A scatter plot showing the percentage difference on the y-axis versus daily dose in mg on the x-axis for Gabapentin 100 mg capsules. Data points represent three studies labeled as Study a, Study b, and Study c, with differences increasing as daily dose rises from 600 mg to 1800 mg.*

FDA Label Image

Label (Lbl721621532)

Gabapentin Capsules USP 100 mg oral capsules label showing 100 capsules per container. The label includes storage instructions for controlled room temperature and a warning to keep out of reach of children. The product is relabeled by Bryant Ranch Prepack and manufactured by ScieGen Pharmaceuticals, Inc. The NDC number 72162-1532-1 is displayed along with barcodes and QR code.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.